Annual Revenue
$658.00 K
-$110.00 K-14.32%
December 31, 2022
Summary
- As of February 10, 2025, VBLT annual revenue is $658.00 thousand, with the most recent change of -$110.00 thousand (-14.32%) on December 31, 2022.
- During the last 3 years, VBLT annual revenue has risen by +$96.00 thousand (+17.08%).
Performance
VBLT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
June 30, 2023
Summary
- VBLT quarterly revenue is not available.
Performance
VBLT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
June 30, 2023
Summary
- VBLT TTM revenue is not available.
Performance
VBLT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
VBLT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | - | - |
| 3 y3 years | +17.1% | - | - |
| 5 y5 years | -95.3% | - | - |
VBLT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.3% | at low | ||||
| 5 y | 5-year | -28.6% | -14.6% | ||||
| alltime | all time | -95.3% | -14.6% |
Vascular Biogenics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $658.00 K(-14.3%) | - | - |
| Sep 2022 | - | $481.00 K(+651.6%) | $854.00 K(+49.3%) |
| Jun 2022 | - | $64.00 K(-43.4%) | $572.00 K(-17.8%) |
| Mar 2022 | - | $113.00 K(-42.3%) | $696.00 K(-9.4%) |
| Dec 2021 | $768.00 K(-16.7%) | $196.00 K(-1.5%) | $768.00 K(-1.2%) |
| Sep 2021 | - | $199.00 K(+5.9%) | $777.00 K(+0.8%) |
| Jun 2021 | - | $188.00 K(+1.6%) | $771.00 K(+4.0%) |
| Mar 2021 | - | $185.00 K(-9.8%) | $741.00 K(-19.6%) |
| Dec 2020 | $922.00 K | $205.00 K(+6.2%) | $922.00 K(+9.4%) |
| Sep 2020 | - | $193.00 K(+22.2%) | $843.00 K(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $158.00 K(-56.8%) | $729.00 K(+2.8%) |
| Mar 2020 | - | $366.00 K(+190.5%) | $709.00 K(+26.2%) |
| Dec 2019 | $562.00 K(-3.9%) | $126.00 K(+59.5%) | $562.00 K(-2.6%) |
| Sep 2019 | - | $79.00 K(-42.8%) | $577.00 K(-3.7%) |
| Jun 2019 | - | $138.00 K(-37.0%) | $599.00 K(-6.6%) |
| Mar 2019 | - | $219.00 K(+55.3%) | $641.00 K(+9.6%) |
| Dec 2018 | $585.00 K(-95.8%) | $141.00 K(+39.6%) | $585.00 K(-95.9%) |
| Sep 2018 | - | $101.00 K(-43.9%) | $14.31 M(+0.7%) |
| Jun 2018 | - | $180.00 K(+10.4%) | $14.21 M(+1.3%) |
| Mar 2018 | - | $163.00 K(-98.8%) | $14.03 M(+1.2%) |
| Dec 2017 | $13.86 M | $13.86 M | $13.86 M |
FAQ
- What is Vascular Biogenics annual revenue?
- What is the all time high annual revenue for Vascular Biogenics?
- What is Vascular Biogenics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Vascular Biogenics?
- What is the all time high TTM revenue for Vascular Biogenics?
What is Vascular Biogenics annual revenue?
The current annual revenue of VBLT is $658.00 K
What is the all time high annual revenue for Vascular Biogenics?
Vascular Biogenics all-time high annual revenue is $13.86 M
What is Vascular Biogenics annual revenue year-on-year change?
Over the past year, VBLT annual revenue has changed by -$110.00 K (-14.32%)
What is the all time high quarterly revenue for Vascular Biogenics?
Vascular Biogenics all-time high quarterly revenue is $13.86 M
What is the all time high TTM revenue for Vascular Biogenics?
Vascular Biogenics all-time high TTM revenue is $14.31 M